ArchiveSCV
the-signal.com. The Santa Clarita Valley Signal. Back to the collection.

· the-signal.com, Wayback capture

Golden State's suit headed for court next year

The multi-million dollar lawsuit brought by Golden State Medical Supply against one of the world's leading pharmaceutical companies is apparently headed for trial, the attorney for the Santa Clarita-based plaintiff said Wednesday.

Golden State Medical Supply, a Valencia Industrial Center firm, could be set for a January court date in its federal fraud and breech of contract suit against Geneva Pharmaceuticals Inc. However, Scott Clarkson, Golden State's attorney, said he doubted the case would come to trial as early as that.

"The trial is set for January but I'd say there's too much discovery to do between now and then," Clarkson said.

Recently the case had to be assigned to a different judge. Clarkson said the judge originally assigned to the case was forced the recuse himself because he owns stock in the insurance company that carries Geneva's policies.

According to court documents, Golden State Medical Supply in 1995 entered into a contract to acquire products from Geneva for repackaging and distribution. The contract called for Golden State to buy products from Geneva solely, while Geneva agreed to use GSMS exclusively as its United State distributor.

The suit, filed in March in United States District Court for the Central District of California, alleges that Geneva did not honor its side of that agreement.

Golden State Medical Supply is seeking $101.5 million in damages. The original suit was amended several months ago to include specific examples and dates of that alleged breeches of contract and fraud.

Clarkson said both sides have engaged in settlement discussions but no agreement was reached, leading him to believe that it would go to trial some time next year.

"There have been no counterclaims by Geneva, and obviously that's a good sign," Clarkson said. "We're in the process of discovery and that will determine the amount of the damages. But from what we've seen, it appears millions and millions of dollars of pharmaceuticals have been sold in (alleged) violation of the contract."

GSMS, which claims annual revenues of about $6.9 million, specializes in what the industry calls "unit of use" packaging, which repackages medications in amounts most commonly prescribed by doctors. This innovation relieves pharmacists of the necessity of counting the number of pills for most prescriptions.

← Back to 1998

About this record

How it was held, read and classified

Record details

Morris ID
Not a Morris ID. This record is keyed ts-df:/business/0998/091098a.html.
System
date-file pages (/desk/MMYY/MMDDYY.html)
Reading copy
the-signal.com
Chosen by: only copy held. On this copy: words 371 (e-mail addresses counted as one token); reader comments 0 (counted, not reproduced here); images 0.
Extracted by
datefile:SLUG_to_rule
signal-extract/0.15 (2026-11-16)

Other copies

Held
None. The holding has this article from one host only.

How it was classified

Label
clearly-local
Judgment
A machine’s (recorded as machine), kept as one so it can be revisited.
Classifier
signal-localclass/0.7 (2026-11-12)
Local signals
  • url:datefile_business
  • text:valley_names [2 distinct/2 mentions: Santa Clarita, Valencia]
  • byline:named_writer_no_wire_credit [By JACK KATZANEK]
National signals
none fired
Scores
local 7, national 0